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Abstract Mutations in NADH dehydrogenase (ND) subunits
of complex I lead to mitochondrial encephalomyopathies
associated with various phenotypes. This report aims to pres-
ent the patient’s clinical symptomatology in the context of a
very rare 13042G>A de novo mutation and with an emphasis
on changing phenotypic expression and pronounced, long-
standing response to levetiracetam.
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Mutations in NADH dehydrogenase (ND) subunits of com-
plex I lead to mitochondrial encephalomyopathies associated
with various phenotypes (Lim et al. 2009). We have recently
described a 13042G>A de novo mutation in a patient with an
overlapping mitochondrial encephalopathy with lactic acido-
sis and strokelike episodes (MELAS) and myoclonic epilepsy
with ragged red fibres (MERRF) clinical features. Genotyping
for common mitochondrial mutations was negative, but clin-
ical phenotype and the muscle biopsy suggested a mitochon-
drial disease. Thus, further genetic testing was performed and
revealed a very rare 13042G>Amutation (Slawek et al. 2012).
This report aims to present the patient’s clinical symptomatol-
ogy in the context of a rare mutation and with an emphasis on
pronounced and long-standing response to levetiracetam
(LVT).
A 26-year-old Caucasian male, with unremarkable family
history, was asymptomatic until the age of 18whenmyoclonic
jerks of the right upper extremity appeared followed by per-
sistent headache, nausea and vomiting. At the age of 20
generalized (probably secondary) epileptic seizures occured.
Valproate administration increased number of seizures and he
was switched to oxcarbazepine (600 mg BID), which resulted
in remission of seizures.
Neurological examination at the age of 21 showed
myoclonic jerks of the right upper extremity at rest as
well as with posturing. Myoclonic jerks were exacerbated
with physical exercise and emotional stress and severely
interfered with precise hand movements. After the next
10 months myoclonic jerks appeared proximally in the
left upper extremity followed by ataxia, brisk tendon
reflexes at the right side, writer’s cramp and startle
reaction (see Video, Segment 1).
Laboratory studies performed at the age of 22
showed a normal serum lactic acid level of 9.45 mg%
with an abnormal lactic acid curve during ischaemic
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muscle exercise. Creatine kinase activity was within the
normal range. A 50 min video EEG disclosed a pattern
characteristic for myoclonic epilepsy. Visual evoked po-
tentials showed delayed P100 responses. Electromyogra-
phy and nerve conduction studies were within normal
ranges. Magnetic Resonance Imaging (MRI) showed
multifocal hyperintensive lesions on T2 and FLAIR
images in the right cerebral peduncle, close to the
occipital horns of the lateral ventricles, in the left tem-
poral lobe as well as in both frontal and parietal lobes
(Fig. 1, segment a and b). Additionally, Magnetic Res-
onance Spectroscopy (MRS) indicated elevated lactate
levels within the previously specified areas.
The myoclonic jerks of upper limbs persisted despite
the oxcarbazepine treatment. Therefore at the age of 22 the
treatment was changed to levetiracetam 2 g daily with an
excellent outcome—myoclonic movements significantly di-
minished (Unified Myoclonus Rating Scale score de-
creased from 69 to 18 points after 2 months). The pa-
tient’s quality of life improved dramatically and he was
able to continue his education at the Technical University
(see Video, Segment 2).
Improvement after LVT was seen over 36 months until
other symptoms (beside myoclonic jerks) significantly
handicapped our patient. At the age of 26 (5 years after
the initial examination) he presented with generalized
choreatic movements, exotropia in the right eye, vertical
gaze limitation (especially downgaze), increased tendon
reflexes on the left side, broad-based unsteady gait, dis-
equilibrium and generalized ataxia. Ophtalmological ex-
amination revealed significant progression of optic nerve
atrophy. A routine MRI scan showed new T2-weighted
hyperintensities bilaterally in the thalamus and brainstem,
which corresponded with the observed deterioration of
the patient’s neurological status (Fig. 1, segment c, d)
(see Video, Segment 3).
Mild cognitive dysfunction was stable at follow-up
neuropsychological examinations at the age of 24 and
26. However, emotional deficits (leading to breakdown
of relationships) and anosognosia progressed over time.
The patient denied any psychological problems and
failed to recognize the implications of motor symptoms
(e.g. he continued to drive and engage in risky physical
activity, unadjusted to his health state, ignoring medical
recommendations).
During 5 years observation of the patient with de
novo 13042 G>A mutation in subunit ND5 of mito-
chondrial complex I (CI) and overlapping symptomatol-
ogy of MELAS, MERRF, PEO (progressive external
ophthalmoplegia) and finally of LHON (Leber’s heredi-
tary optic neuropathy) was noticed. Recently, there has
been increased interest in the DNA gene encoding sub-
unit 5 of complex I (MT-ND5), as a mutation hot spot
for several overlap syndromes (Blok et al. 2007).
Although13042G>A mutation was described earlier by
Naini et al. (2005), we present a patient with a de novo
mutation and long-term follow-up. This long-term ob-
servation shows the very complex pattern of neurologi-
cal abnormalities evolving during 5 years from epilepsy,
myoclonus and dystonia to choreatic movements with
ophtalmoplegia and optic neuropathy.
In conclusion we suggest levetiracetam as a good symp-
tomatic treatment of disabling myoclonus.
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Fig. 1 MRI T2 and Flair. Images (a) and (b) performed at the age of 22.
(a) Hyperintensive lesion in right cerebral peduncle (b) hyperintensive
cortical lesions in the frontal and parietal lobes bilaterally. Images (c) and
(d) performed at the age of 26. (c) Hyperintensive lesion in left thalamus
(d) symetrical dorsal hyperintensities of brainstem
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